Sfoglia per AUTORE
AUDISIO E
Collezione AOU Novara

  

Items : 7

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. in Haematologica / Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448.

2025
AOU Città della Salute di Torino
AOU Novara

Huls G; Valent P; Eisfeld AK; Albano F; Visani G; DiBona E; Roti G; Rigolin GM; Marvalle D; Audisio E; Festuccia M; Venditti A; Forghieri F; Galimberti S; Lanza F; Pullarkat S; Lunghi M; Gotlib JR; Candoni A; Capelli D; Deeg HJ; Gurrieri C; Yeung CCS; Cairoli R; Morgan EA; Ferrara F; Marcucci G; Papayannidis C; Tecchio C; et alii...

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting. in Cancer / Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. in Blood / Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625.

2024
AOU Città della Salute di Torino
AOU Novara

Fazi P; Mengarelli A; Legrand O; Baron F; Candoni A; Posthuma EFM; Vrhovac R; Venditti A; Gaidano G; Crysandt M; Fuhrmann S; Foà R; Audisio E; Luppi M; Neubauer A; Griskevicius L; Chantepie S; Noppeney R; van der Velden WJFM; Coens C; Suciu S; Kicinski M; Efficace F; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

10-day decitabine versus 3?+?7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9.

2023
AOU Città della Salute di Torino
AOU Novara

Becker H; Blijlevens N; Wäsch R; Vilque JP; Ammatuna E; Efficace F; de Graaf AO; Stevens-Kroef M; Jansen JH; Hoogendoorn M; Giraut A; Posthuma EFM; van Lammeren-Venema D; Gaidano G; Foà R; Legrand O; Candoni A; Audisio E; Fuhrmann S; Luppi M; Vrhovac R; Crysandt M; Neubauer A; Griškevi?ius L; Noppeney R; Van der Velden WJFM; Chantepie S; Kicinski M; Wijermans PW; et alii...

Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study. in British journal of haematology / Br J Haematol. 2023 Feb;200(4):440-450. doi: 10.1111/bjh.18537. Epub 2022 Nov 6.

2023
AOU Città della Salute di Torino
AOU Novara

Pizzolo G; Ferrara F; Candoni A; Di Renzo N; Krampera M; Cerrano M; La Starza R; Trappolini S; Imovilli A; Tanasi I; Cedrone M; Pasciolla C; Lazzarotto D; Annunziata M; Del Principe MI; Guolo F; Todisco E; Lunghi M; Scattolin AM; Forghieri F; Defina M; Scappini B; Zappasodi P; Audisio E; Giglio F; Salutari P; Papayannidis C; Fracchiolla NS; Vitale A; et alii...

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients. in Expert review of hematology / Expert Rev Hematol. 2017 Jun;10(6):543-550. doi: 10.1080/17474086.2017.1326813. Epub 2017 May 24.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

De Rosa FG; Squadrone V; Mengozzi G; Caropreso P; Saglio F; Berger M; Corcione S; Micalizzi C; Faraci M; Corsetti A; Depaoli L; Audisio E; Festuccia M; Nassi L; Cignetti A; Raviolo S; Mordini N; Giaccone L; Busca A; Vallero S; Bruno B;